The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Safety and Biologic Response of Pre-operative Autophagy Inhibition in Combination with Gemcitabine in Patients with Pancreatic Adenocarcinoma
Open accessAbstract
Purpose Autophagy is a cell survival mechanism that plays a critical role in pancreatic carcinogenesis. Murine studies have previously demonstrated that treatment with the late-autophagy inhibitor chloroquine in combination with chemotherapy limited tumor growth.Methods In this phase 1/2 trial, we examined treatment with hydroxychloroquine (HCQ) and gemcitabine for patients with pancreatic adenocarcinoma. The primary endpoints were safety and tolerability, evaluated by Storer's dose escalation design. Secondary endpoints were CA 19-9 biomarker response, R0 resection rates, survival, and correlative studies of autophagy.Results Thirty-five patients were enrolled. There were no dose-limiting toxicities and no grade 4/5 events related to treatment. Nineteen patients (61 %) had a decrease in CA 19-9 after treatment. Twenty-nine patients (94 %) underwent surgical resection as scheduled, with a 77 % R0 resection rate. Median overall survival was 34.8 months (95 % confidence interval, 11.57 to not reached). Patients who had more than a 51 % increase in the autophagy marker LC3-II in circulating peripheral blood mononuclear cells had improvement in disease-free survival (15.03 vs. 6.9 months, p < 0.05) and overall survival (34.83 vs. 10.83 months, p < 0.05). No outcome differences were demonstrated in the 81 % of patients with abnormal p53 expression assessed by immunohistochemistry in the resected specimens.Conclusions Preoperative autophagy inhibition with HCQ plus gemcitabine is safe and well tolerated. Surrogate biomarker responses (CA 19-9) and surgical oncologic outcomes were encouraging. p53 status was not associated with adverse outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mitophagy, the selective engulfment and degradation of mitochondria through autophagy, has also been shown to be important in PDAC tumorigenesis in mice and organoid models211”
From Pancreatic cancer: Advances and challenges (2023) · cites this paper as [211]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Clavien-Dindo Classification of Surgical Complications: Five-Year Experience
Clavien, P. A., Barkun, J., de Oliveira, M. L., Vauthey, J. N., Dindo, D., Schulick, R. D., de Santibañes, E., Pekolj, J., Slankamenac, K., Bassi, C., et al. (2009) · Annals of Surgery · doi:10.1097/sla.0b013e3181b13ca2 · Cited by 11,482
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
Conroy, T., Desseigne, F., Ychou, M., Bouché, O., Guimbaud, R., Bécouarn, Y., Adenis, A., Raoul, J.-L., Gourgou-Bourgade, S., de la Fouchardière, C., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1011923 · Cited by 7,810
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
Von Hoff, D. D., Ervin, T., Arena, F. P., Chiorean, E. G., Infante, J., Moore, M., Seay, T., Tjulandin, S. A., Ma, W. W., Saleh, M. N., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1304369 · Cited by 6,712
Self-citationPostoperative pancreatic fistula: An international study group (ISGPF) definition
Bassi, C., Dervenis, C., Butturini, G., Fingerhut, A. L., Yeo, C. J., Izbicki, J. R., Neoptolemos, J. P., Sarr, M. G., Traverso, W. L., & Büchler, M. W. (2005) · Surgery · doi:10.1016/j.surg.2005.05.001 · Cited by 4,280
Guidelines for the use and interpretation of assays for monitoring autophagy
Klionsky, D. J., Abdalla, F. C., Abeliovich, H., Abraham, R. T., Acevedo-Arozena, A., Adeli, K., Agholme, L., Agnello, M., Agostinis, P., Aguirre-Ghiso, J. A., et al. (2012) · Autophagy · doi:10.4161/auto.19496 · Cited by 3,996
Pancreatic cancers require autophagy for tumor growth
Yang, S., Wang, X., Contino, G., Liesa, M., Sahin, E., Ying, H., Bause, A., Li, Y., Stommel, J. M., Dell'Antonio, G., et al. (2011) · Genes & Development · doi:10.1101/gad.2016111 · Cited by 1,498
Design and Analysis of Phase I Clinical Trials
Storer, B. E. (1989) · Biometrics · doi:10.2307/2531693 · Cited by 939
Principles and Current Strategies for Targeting Autophagy for Cancer Treatment
Amaravadi, R. K., Lippincott‐Schwartz, J., Yin, X., Weiss, W. A., Takebe, N., Timmer, W. C., DiPaola, R. S., Lotze, M. T., & White, E. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2634 · Cited by 912
Self-citationPreoperative Chemoradiation and Pancreaticoduodenectomy for Adenocarcinoma of the Pancreas
Evans, D. B. (1992) · Archives of Surgery · doi:10.1001/archsurg.1992.01420110083017 · Cited by 771
p53 status determines the role of autophagy in pancreatic tumour development
Rosenfeldt, M. T., O’Prey, J., Morton, J. P., Nixon, C., MacKay, G., Mrowinska, A., Au, A., Rai, T. S., Zheng, L., Ridgway, R., et al. (2013) · Nature · doi:10.1038/nature12865 · Cited by 713
Research works printed but not linked: 1
- Bao P, Potter D, Eisenber DP, Lenzner D, Zeh HJ, Lee KK, et al. Validation of a prediction rule to maximize curative (R0) resection of early-stage pancreatic adenocarcinoma. HPB (Oxford). 2009;11:606–11. · DOI
Cited by
Sorted by citations
Items 201–238 of 238
Bai, X., Xiong, J., Li, L., Yu, C., & Sun, C. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176431 · Cited by 1
GOT2: New therapeutic target in pancreatic cancer
Bu, J., Miao, Z., & Yang, Q. (2024) · Genes & Diseases · doi:10.1016/j.gendis.2024.101370 · Cited by 1
Bisoi, A., Majumdar, T., Sarkar, S., & Singh, P. C. (2025) · Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.5c00526 · Cited by 1
The Expendables: Overlooked Medications with Anti-Cancer Properties
Deshpande, A. J., Munoz, J. L., & Kurzrock, R. (2025) · Current Oncology Reports · doi:10.1007/s11912-025-01721-y · Cited by 2
Amr, E., El-Feky, O. A., El-Ashmawy, N., & Khedr, E. (2025) · Biochimica et Biophysica Acta. Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2025.195131 · Cited by 1
Wang, Z., Lyu, Z., Palmen, R., Bao, Q., Popp, F., Dong, Q., Bruns, C. J., & Zhao, Y. (2026) · Cell Death Discovery · doi:10.1038/s41420-026-02948-9 · Cited by 1
Autophagic processes of normal and malignant metabolic pathways
Udriştioiu, A., & Cojocaru, M. (2019) · African Journal of Biological Sciences · doi:10.33472/afjbs.1.3.2019.1-13
Endoplasmic Reticulum Stress and Autophagy in Cancer
Tan, M., Tan, H. K., & Muhammad, T. S. T. (2020) · Springer eBooks · doi:10.1007/978-3-030-30845-2_18 · Cited by 1
Autophagy and Multidrug Resistance in Cancer
Agnihotri, T. G., Gomte, S. S., Peddinti, V., Rout, B., Bishlay, J., Pandey, A. K., & Jain, A. (2024) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-3-031-66421-2_5 · Cited by 2
Autophagy in head and neck cancer therapy
Lee, Y.-S., Eckers, J. C., & Kimple, R. J. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-817868-3.00013-5 · Cited by 1
The Autophagy Conundrum in Cancer Development, Progression and Therapeutics
Nagini, S., Palrasu, M., & Malla, R. R. (2020) · Springer eBooks · doi:10.1007/978-981-15-6930-2_11 · Cited by 1
Prognostic Autophagy-Related Genes of Gastric Cancer Patients on ChemotherapyPreprint
Liu, X., Ma, Z., Zhang, L., Yu, Y., Paul, M. E., Ma, Y., Leng, Y., & Chen, H. (2020) · Research Square · doi:10.21203/rs.3.rs-132739/v1 · Cited by 1
Metabolism in Pancreatic Cancer
Poursaitidis, I., & Lamb, R. F. (2017) · Springer eBooks · doi:10.1007/978-1-4939-6631-8_68-1
Apalutamide and autophagy inhibition in xenograft mouse model of human prostate cancer
Salemi, S., Kranzbühler, B., Prause, L. W., Baumgartner, V., & Eberli, D. (2021) · European Urology · doi:10.1016/s0302-2838(21)00820-4
ANXA1 Induces Oxaliplatin Resistance of Gastric Cancer through Autophagy by Targeting PI3K/AKT/mTORPreprint
Ren, J., Hu, Q., Niu, M. G., Xia, J. L., Wang, X., Hong, Q. R., Gu, W. J., & Ke, C. (2021) · Research Square · doi:10.21203/rs.3.rs-895675/v1
Prognostic Implications of an Autophagy-related Gene Signature in Pancreatic Ductal Adenocarcinoma
Liu, W.-S., Feng, Y.-X., Li, S.-N., Shao, Y.-J., & Wang, K. (2022) · American Journal of Clinical Oncology · doi:10.1097/coc.0000000000000890
Jiménez-Rodríguez, R. M., & Weiser, M. R. (2018) · Current Problems in Surgery · doi:10.1067/j.cpsurg.2018.08.001
Prognostic Autophagy-Related Genes of Gastric Cancer Patients on ChemotherapyPreprint
Liu, X., Ma, Z., Yu, Y., Paul, M. E., Ma, Y., Bai, Y.-P., Li, X., Gu, B., Qi, W., & Chen, H. (2020) · Research Square · doi:10.21203/rs.3.rs-92085/v1
Prognostic Autophagy-Related Genes of Gastric Cancer Patients on ChemotherapyPreprint
Liu, X., Ma, Z., Zhang, L., Yu, Y., Paul, M. E., Ma, Y., Leng, Y., & Chen, H. (2021) · Research Square · doi:10.21203/rs.3.rs-132739/v2
Interrelations between Apoptosis and Autophagy in Autoimmune and Malignant Diseases
Udriştioiu, A., Martin, A., Giubelan, A., Papurica, M. D., Daniela, M. V.-W., Martin, L., & Nica-Badea, D. (2022) · Medical Research Archives · doi:10.18103/mra.v10i6.2886
Тилляшайхов, М. Н., Viktorovich, K. S., & Теджпар, С. (2020) · Евразийский онкологический журнал · doi:10.34883/pi.2020.8.1.021
Nakata, K., Oyama, K., Tsutsumi, C., Hayashi, M., Zhang, B., Mochida, Y., Shinkawa, T., Zhong, P., Date, S., Luo, H., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-3419957/v1
Chauhan, N., Majumdar, A. G., Bhutia, S. K., Dey, P., Subramanian, M., & Patro, B. S. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.07.674530
Roos-Mattila, M., Mustonen, H. K., Vähä-Koskela, M. J. V., Boyd, S., Vainionpää, S., Hwang, R. F., Puolakkainen, P. A., Joncour, V. L., Laakkonen, P. M., & Seppänen, H. E. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.11.04.686484
Zhou, L., Huo, M., Qian, X., Ding, L., Yu, L., Feng, W., Cui, X., & Chen, Y. (2021) · Figshare · doi:10.6084/m9.figshare.14457263
Koh, Y., Kim, H., Joo, S. Y., Song, S., Choi, Y. H., Kim, H. R., Moon, B., Byun, J., Hong, J., Shin, D.-Y., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26627839
Koh, Y., Kim, H., Joo, S. Y., Song, S., Choi, Y. H., Kim, H. R., Moon, B., Byun, J., Hong, J., Shin, D.-Y., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26627827
Koh, Y., Kim, H., Joo, S. Y., Song, S., Choi, Y. H., Kim, H. R., Moon, B., Byun, J., Hong, J., Shin, D.-Y., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26627830
Wang, Y., Xu, T., Wang, H., Xia, G., & Huang, X. (2024) · Figshare · doi:10.6084/m9.figshare.26241228
Koh, Y., Kim, H., Joo, S. Y., Song, S., Choi, Y. H., Kim, H. R., Moon, B., Byun, J., Hong, J., Shin, D.-Y., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26627836
Koh, Y., Kim, H., Joo, S. Y., Song, S., Choi, Y. H., Kim, H. R., Moon, B., Byun, J., Hong, J., Shin, D.-Y., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26627833
Koh, Y., Kim, H., Joo, S. Y., Song, S., Choi, Y. H., Kim, H. R., Moon, B., Byun, J., Hong, J., Shin, D.-Y., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26627842
Molins, E. A. G. (2020) · theses.fr (ABES) · doi:10.70675/252d1be2z22e8z4378zb146zfd4ec7fa46a7
Contrôle de l'oncogenicité de Kras et isoforme beta de PI3K dans la cancérogenèse du pancréas
Arcucci, S. (2019) · theses.fr (ABES) · doi:10.70675/bd0f6cf8zac49z4e36zbe80z39b5e2b4e43a
Guo, X., Cheng, H., Wang, D., Wang, Z., Hu, Q., & Zhang, Y. P. (2026) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2026.154197
Chauhan, N., Majumdar, A. G., Bhutia, S. K., Dey, P., Subramanian, M., & Patro, B. S. (2026) · Autophagy · doi:10.1080/15548627.2026.2693263
Autophagy inhibition in pancreatic cancer: hope or hype?
Guilbaud, E., Cukierman, E., Astsaturov, I. A., & Galluzzi, L. (2026) · Autophagy Reports · doi:10.1080/27694127.2026.2721748
Metadata
- Authors
- Boone, B. A., Bahary, N., Zureikat, A. H., Moser, A. J., Normolle, D. P., Wu, W.-C., Singhi, A. D., Bao, P., Bartlett, D. L., Liotta, L. A., Espina, V., Loughran, P., Lotze, M. T., & Zeh, H. J.
- Affiliations
- University of Pittsburgh (US)
- Beth Israel Deaconess Medical Center (US)
- George Mason University (US)
- Corresponding author
- Lotze, Michael T.
- Zeh, Herbert J.
- ORCID
- Venue
- Annals of Surgical Oncology
- Published
- 2015-04-24
- Volume
- 22
- Issue
- 13
- Pages
- 4402-4410
- ISSN
- 1068-9265 (ISSN-L)
- 1534-4681
- PMC
- PMC4663459
- OpenAlex
- W2018872699
- Cited by
- 234
- References
- 52
- Citations by year
- 2026: 9 · 2025: 13 · 2024: 24 · 2023: 21 · 2022: 23 · 2021: 37 · 2020: 32 · 2019: 20 · 2018: 27 · 2017: 18 · 2016: 8 · 2015: 2
- FWCI
- 8.01
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Annals of Surgical Oncology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (L30 CA170992, R01CA181450, P30CA047904, T32CA113263)
- Topics
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Health Sciences › Medicine › Surgery › Pancreatitis Pathology and Treatment
- Keywords
- pancreatic ductal adenocarcinoma, autophagy inhibition, hydroxychloroquine, gemcitabine, neoadjuvant therapy, CA19-9, LC3-II, p53, R0 resection, overall survival, safety and tolerability, biomarker response
- MeSH terms
- Gemcitabine, Adenocarcinoma, Adult, Aged, Aged, 80 and over, Antimetabolites, Antineoplastic, Autophagy, Deoxycytidine, Drug Therapy, Combination, Female, Follow-Up Studies, Humans, Hydroxychloroquine, Immunoenzyme Techniques, Male, Middle Aged, Neoplasm Staging, Pancreatic Neoplasms, Prognosis, Prospective Studies, Safety, Biomarkers, Survival Rate, CA-19-9 Antigen, Antirheumatic Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
